3-Ethyl-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one

Catalog No. :
ACTUDA992
CAS No. :
624724-23-8
Molecular Formula :
C26H27N3O2S2
Molecular Weight :
477.65

IUPAC Name:(Z)-3-ethyl-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one

3-Ethyl-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Ethyl-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one
IUPAC Name(Z)-3-ethyl-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one
MDL No.MFCD03663011
Molecular FormulaC26H27N3O2S2
Molecular Weight477.65
SMILESO=C1N(CC)C(S/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(OCC(C)C)C(C)=C4)=S
InChI KeySTRGOOPTCAUBHV-UCQKPKSFSA-N
SynonymSALOR-INT L422789-1EA;(5Z)-3-ETHYL-5-([3-(4-ISOBUTOXY-3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE)-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 3-ethyl-5-[[3-[3-methyl-4-(2-methylpropoxy)phenyl]-1-phenyl-1H-pyrazol-4-yl]methylene]-2-thioxo-
CAS No.624724-23-8

Synthetic Route by SureRoute

1. ACTUDA992 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTUDA992 route product structure diagram
    ACTUDA992624724-23-8
Inquiry

2. ACTUDA992 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTUDA992 route product structure diagram
    ACTUDA992624724-23-8
Inquiry

Comments (0)